0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
38 Ansichten5 Seiten
"Cancer risk among users of oral contraceptives: cohort data from The Royal College of general practitioners' oral contraception study" "#$%. '(( -omen -ho -ere married or living in a stale relationship and most -erre -e -e never used them.""
"Cancer risk among users of oral contraceptives: cohort data from The Royal College of general practitioners' oral contraception study" "#$%. '(( -omen -ho -ere married or living in a stale relationship and most -erre -e -e never used them.""
"Cancer risk among users of oral contraceptives: cohort data from The Royal College of general practitioners' oral contraception study" "#$%. '(( -omen -ho -ere married or living in a stale relationship and most -erre -e -e never used them.""
Practicing and Teaching Evidence-Based Health Care in Other Clinical
Specialties
4. Appendix: Critical appraisal worsheets HA!" #O!$SHEET Citation: Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioners oral contraception study. Are the res%lts o& this har' st%d( valid) Were there clearly defined groups of patients, similar in all important ways other than exposure to the treatment or other cause? Ada Di bagian method dijelaskan bahwa penelitian The Royal ollege of !eneral "ractitioners# oral contraception dimulai pada $ei %&'( selam %) bulan oleh %)** dokter umum dengan merekruit sekitar +,*** wanita yang mengunakan kontrasepsi oral dan sekitar +,*** wanita yang tidak menggunakan oral kontrasepsi- .emunya rata berumur +& tahun, sudah menikah, tinggal dalam hubungan yang stabil- Dalam penelitian informasi baseline yang dikumpulkan meliputi kebiasaan merokok, kelas social/pekerjaan suami0, kesimbangan, dan pentingnya medical history- 1The Royal College of General Practitioners oral contraception study egan in !ay "#$%. &ver a "' month period "'(( general practitioners throughout the )nited *ingdom recruited aout +, ((( -omen -ho -ere using oral contraceptives and +, ((( -omen -ho had never used them."" The mean age at recruitment -as +# .standard deviation $.$/. 0ll the -omen -ere married or living in a stale relationship and most -ere -hite. 1aseline information collected included smoking haits2 social class .ased on husands occupation/2 parity2 and important medical history Were treatments2exposures and clinical outcomes measured in the same ways in both groups /was the assessment of outcomes either objecti3e or blinded to exposure0? 4ya, ada pada bagian method 5 0fter recruitment the general practitioners supplied information every si3 months aout any hormonal preparations prescried2 any pregnancies and their outcome2 all ne- episodes of illness .including cancer/2 and any surgery in -omen still under their oservation. "ada method dijelaskan bahwa semua wanita yang direkruitmen baik yang menggunakan kontrasepsi oral maupun wanita yang tidak mengggunakan kontrasepsi oral difollow up sama- $ereka setiap enam bulan diberi 2 informasi mengenai hormonal, macam6macam kehamilan, dan outcome mereka penelitian, semua episode penyakit/ termasuk kanker0 dan berbagai operasi- Was the follow6up of study patients sufficiently long and complete? Dari penelitian di atas follow up yang dilakukan panjang- 7al tersebut dilihat dari penyakit yang diteliti yaitu apakah kontrasepsi oral menyebabkan resiko cancer- Durasi rata6rata kontrasepsi oral yang digunakan untuk penelitian antara lain )) bulan / range inter8uatil %& sampai (, bulan , range %6 ,)) bulan0- "enelitian di mulai $ei %&'( sampai Desember +**)- Dan follow up yang dilakukan tidak komplet karena participant dan dokter yang meningalkan lebih dari +*9 yaitu +)9 wanita tidak ditandai karena mereka dan dokter mereka meninggalkan penelitian ini- Do the results satisfy some 1diagnostic tests for causation:? 4s it clear that the exposure preceded the onset of the outcome? ;a Dijelaskan di table <low chart of Royal !eneral "ractitioners# oral contraception study- =alues refer to numbers of women unless stated otherwise- Tetapi kontrasepsi oral bukan merupakan faktor langsung kanker- "emeriksaan risiko absolute dan keuntungan pada kanker dihubungkan dengan pemakaian kontrasepsi oral tergantung pada model2type kontrasepsi oral yang digunakan dan insiden dari berbagai macam kanker- Conclusion 4n this )* cohort2 oral contraception -as not associated -ith an overall increased risk of cancer5 indeed it may even produce a net pulic health gain. The alance of cancer risks and enefits2 ho-ever2 may vary internationally2 depending on patterns of oral contraception usage and the incidence of different cancers. 4s there a dose> response gradient? Tidak dijelaskan- 4s there positi3e e3idence from a 1dechallenge> rechallenge: study? Tidak dijelaskan- 4s the association consistent from study to study? ?onsisten bahwa penggunaan kontrasepsi meningkatkan resiko kanker payudara, cer3ic, dan hati- Does the association make biological sense? ?anker yang disebabkan secara tidak langsung oleh penggunaan kontrasepsi oral, risiko kanker dan keuntungannya tergantung pada model2type kontrasepsi oral yang digunakan dan insiden dari 3 berbagai macam kanker- Are the valid res%lts &ro' this har' st%d( i'portant) What is the magnitude of the association between the exposure and outcome?
What is the precision of the estimate of the association between exposure and outcome?
Ad3erse outcome *nvasive cancer Totals "resent /case0 Absent /control0 @xposed to the treatment $ontrasepsi Oral ;es /cohort0 a +4,- b ./0+ aAb .-1 Bo /cohort0 c +1 d -42. cAd ,401 Totals aAc /.33 bAd ---+ aAbAcAd ,1-+ 4n a randomiCed trial or cohort study5 !elative !is4!!0 DEa2/aAb0F2Ec2/cAd0F DEGH2%H'F2E,*+H2()&'F D*,)(2*,,' D%,, Iadi Relati3e Risk penelitian ini adalah %,, 55T
4n a case>control study5 odds ratio /or relati3e odds0DJRDad2bc- 4 Sho%ld these valid6 potentiall( i'portant res%lts change the treat'ent o& (o%r patient) 7o the res%lts appl( to o%r patient) 4s our patient so different from those in the study that its results don#t apply? 6 What are our patient#s risks of the ad3erse e3ent? To calculate the BB7 /number of patients we need to treat to harm one of them0 for any odds ratio /JR0 and our patient#s expected e3ent rate for this ad3erse e3ent if they were not exposed to this treatment /"@@R05 6 What are our patient#s preferences, concerns and expectations from this treatment? 6 What alternati3e treatments are a3ailable? 6 Additional notes: : 5